Brochure
27 Oct 2021

APPLIVER FIBROSIS

PDF 713 kB

APPLIVER® is the new product obtained by the ABR innovative biotechnological platform NATRISE®.
 Our research studies confirm the beneficial effect on health of APPLIVER® in metabolic disorder as NAFLD.

This makes APPLIVER® the perfect ingredient for dietary supplements and functional foods.

Content provided by our supplier

ABResearch srl

  • IT
  • 2020
    On CPHI since
  • 3
    Certificates
  • 25 - 49
    Employees
Company types
Contract Service
Manufacturer/Innovator

Other Content from ABResearch srl ()